DOCSLIB.ORG

A AAST. See American Association for the Surgery of Trauma Abdominal Aortic Aneurysms, 399–400 Abdominal Complications, 325–

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A AAST. See American Association for the Surgery of Trauma Abdominal Aortic Aneurysms, 399–400 Abdominal Complications, 325– Index A duodenal, 537 American Heart Association (AHA), 120 AAST. See American Association for the epidemiology of, 363–364 American Joint Committee on Cancer Surgery of Trauma pathology of, 362–363 (AJCC), 386, 462 Abdominal aortic aneurysms, 399–400 rectal, 365 American Medical Association, 729 Abdominal complications, 325–327 serrated, 368 American Society of Anesthesiologists Abdominal injuries, 327 surveillance of, 365–366 (ASA), 117, 171 Abdominal rectopexy, 666, 669–671 Adenomatous polyps, 356–357 American Society of Colon and Rectal Abdominal transsacral resection, 432 Adenosquamous carcinoma, 521 Surgeons (ASCRS), 120, 281, 353, Abdominal wall closure, 327 Adjuvant therapy, 428, 433, 437–443 390, 654, 703, 707, 767 Abdominoperineal resection (APR), 146, ADL. See Activities of daily living Amine precursor uptake and 413, 432 Adrenergic antagonists, 185 decarboxylation (APUD), 515 ligation/resection during, 419–422 Advance directives, 745–747 Amines, 516 mobilization during, 419 Advancement flaps, 182, 204, 217–219 Aminosalicylates, 555 position during, 419 Aeromonas, 607, 609–610 Amitriptyline (Elavil), 684 techniques of, 419–422 Age, 271, 386 Ammonium derivatives, 685 Abscess, 274, 279. See also Acute Agency for Health Care Policy and Amoxicillin, 124 suppuration; Anorectal abscess Research (AHCPR), 353, 354, 358 Ampicillin, 331, 416 enteroparietal, 592–593 AHA. See American Heart Association Amsterdam criteria, 529, 530 interloop, 593 AHCPR. See Agency for Health Care Anal agenesis, 17 intraabdominal, 151–152 Policy and Research Anal canal intramesenteric, 593 AIDS (acquired immunodeficiency anus and pilonidal disease, 229 syndrome) anatomic v. surgical, 1, 2 psoas/retroperitoneal, 593 diarrhea, 614–615 conjoined longitudinal muscle and, Absolute risk reduction (ARR), 772 HIV, 265–266 3–4 ACC. See American College of Cardiology AIN. See Anal intraepithelial neoplasia epithelium of, 2, 4 Accrediting Council for Graduate Medical AJCC. See American Joint Committee on external anal sphincter and, 2–3 Evaluation (ACGME), 782–783 Cancer innervation of, 7–8, 9 Aclovate®. See Alclometasone dipropionate Alclometasone dipropionate (Aclovate®), internal anal sphincter and, 2 Acromegaly, 344 252 muscles of, 2, 3 Actinomycosis, 607, 610 Alcohol, 271, 340 structure/anal verge, 1 Activities of daily living (ADL), 119 Aldosterone, 24–25 length of, 49 Acupressure, 132 Amebiasis, 612 neoplasms, EAUS and, 111–112 Acupuncture, 132 American Association for the Surgery of physiology of Acute colonic obstruction, 399 Trauma (AAST), 323, 327, 328, bulbocavernosus reflexes in, 35 Acute suppuration (abscess), 210 329, 331 cough reflexes in, 35 Acute thrombosis, 165 American Board of Colon and Rectal cutaneous-anal reflexes in, 34 Adenine, 525 Surgery, 783 mechanical factors in, 36–37 Adenocarcinomas, 356–357, 491–492 American Cancer Society, 353, 355, pathologic conditions in, 37–38 Adenoma(s), 533 390, 532 RAER in, 35–36 -carcinoma sequence, 364 American College of Cardiology RAIR in, 35, 36 clinical presentation of, 362 (ACC), 120 reflexes in, 34 depressed/flat, 367–368 American College of Surgeons, 782 sensory in, 34 795 796 Index Anal cancer, 263–265 Angiography, 92–94, 304–305 Aristocort®. See Triamcinolone acetonide anatomic considerations for, 482–483 Anisakiasis, 614 0.5% epidemiology of, 485 Anismus, 50 Armed Forces Institute of Pathology, 520 etiology/pathogenesis of, 483–485 Anoperineum, 591–592 ARR. See Absolute risk reduction HIV-related, 495 Anorectal abscess Arteries, inferior/superior hemorrhoidal, 6 lymphatic drainage and, 483 anatomy of, 192, 193 Artificial bowel sphincter, 661 squarmous cell cancer of the anal canal evaluation/treatments for, 192–198 ASA. See American Society of clinical characteristics and, 488 pathophysiology of, 192, 193 Anesthesiologists evaluation of, 488–489 Anorectal agenesis, 17–18 Ascariasis, 613 staging and, 489 Anorectal angle ASCA testing, 551 treatments for, 489–491 defecography and, 49 ASCRS. See American Society of Colon terminology for, 483 flap valve and, 36 and Rectal Surgeons Anal dilatation ring, 13 ASCUS. See Atypical squamous cells of anal fissure and, 180 Anorectal defects, 17–18 indeterminate significance stretch, 165 Anorectal immunology, 256–257 Aspirin, 340–341 Anal diseases, 244 Anorectal infections, 197 Association of Surgeons (Netherlands), 782 Anal dysplasia, 483–485 Anorectal malformations (imperforate Astler Coller Modification, 386 Anal encirclement procedures, 659 anus), 16, 17, 716 Atropine, 605, 684 Anal fissure, 725 specific defects associated with Atypical squamous cells of indeterminate conclusions on, 188 females, 718–719, 721–722 significance (ASCUS), 263 Crohn’s disease and, 187 males, 717–718, 719, 720–721 Azathioprine (AZA), 557, 562 diagnosis of, 179 treatment results for, 722–723 Azulfidine®. See Sulfasalazine epidemiology of, 178 Anorectal sepsis, 198 etiology of, 178–179 Anorectal spaces, 9–10 B HIV and, 187–188 Anorectal surgery, 171 Babies, 19, 719 low pressure, 187 Anoscopy Bacitracin, 617–618 management of complications associated with, 58 Bacterial infections, 242–243 advancement flaps in, 182 contraindications for, 57 Balantidiasis, 612 anal dilatation in, 180 indications for, 57, 58 Balloon conservative, 179 positioning in, 57 expulsion test, 51 LIS in, 180–182 preparations for, 57 training, 659 operative treatment in, 179 techniques for, 57–58 Balneol®, 250 medical management of Anterior sacral meningoceles, 502–503 Balsalazide (Colazal®), 556 adrenergic antagonists in, 185 Anterior sphincteroplasty, 659–660 BAM. See Bile acid malabsorption BT in, 182, 185–187 Anthracene, 681 Bannayan-Riley-Ruvalcaba syndrome, 381 calcium channel blockers in, 184–185 Antibiotic(s), 196, 222, 555–556, 561, Barium cholinergic agonists in, 185 587, 617–618. See also specific enemas, 75–76, 293, 355 phosphodiesterase inhibitors in, 182, drugs follow-through, 83 185 for colon/rectal injuries, 330–331 in physiologic testing, 47 sphincter relaxants in, 182 oral, 124 studies, 75 topical nitrates, 182–184 parenteral, 124 Barnet continent ileostomy reservoir symptoms of, 179 prophylaxis, 416 (BCIR), 571 Anal infections, 198 topical, 252 Basal cell carcinomas (BCCs), 493 Anal intraepithelial dysplasia, 263–265 usage of, 122, 124, 126 Bascom cleft lift (Bascom II), 233–234 Anal intraepithelial neoplasia (AIN), 483 Antibodies, monoclonal, 470 Bascom I. See Midline pit excision Anal manometry, 656–657 Anticholinergics, 561, 684 Bascom II. See Bascom cleft lift Anal margin Anticoagulants, 416 Bascom’s chronic abscess curettage, perianal neoplasms/uncommon, 493–495 Anticoagulation, 135, 136 230–231 SCC of Antigens, 439 BCCs. See Basal cell carcinomas clinical characteristics of, 486 Antihistamines, 132, 240, 243, 251 BCIR. See Barnet continent ileostomy staging of, 487 Antineutrophil cytoplasmic antibody reservoir treatment options for, 487–488 (ANCA), 551 Behçet’s syndrome, 602, 603 Anal sphincter, 33, 34, 52 Antispasmodics, 29 Benadryl®. See Diphenhydramine Anal stenosis, 17 APACHE (Acute physiology and chronic Bentyl. See Dicyclomine hydrochloride Anal tattooing, 253 health evaluation), 118 Benzathine penicillin, 260 ANCA. See Antineutrophil cytoplasmic Appendicitis, 276 Betadine, 634 antibody APR. See Abdominoperineal resection Betamethasone dipropionate (Diprolene®), Anesthesia, 132. See also Patient-controlled APUD. See Amine precursor uptake and 252 anesthesia decarboxylation Betamethasone valerate cream (Valisone®), Angiodysplasia, 301 Arc of Riolan, 15 252 Index 797 Bethanechol, 182 Calmoseptine®, 252 Chlamydia trachomatis, 258–259 Bicarbonates, 25 Camphor, 252 Chloride, 25 Bile acid malabsorption (BAM), 605 Campylobacter, 607, 608 Cholecystectomy, 342 Bioethics, 737–739 Canadian Multicentre Colorectal Deep Vein Cholestyramine, 605, 618 Bipolar diathermy, 163–164 Thrombosis Prophylaxis, 135 Cholinergic agonists, 185 Bisacodyl, 681 Canadian Task Force on the Periodic Health Chronic pulmonary diseases, 121 Bisacodyl suppositories, 658 Examination, 767 Chronic suppuration (fistula), 210–211 Bismuth subsalicylate, 605 Cancer(s). See also specific cancers CHRPE. See Congenital hypertrophy of the Bladder injuries, 146 contrast studies of polyps/, 75–77 retinal pigment epithelium Bleeding, 273, 300 hereditary, 447 CI. See Confidence interval as anastomotic postoperative management/risks associated with, 381 Cidofovir, 486 complication, 142–143 MSI-H, 369 Ciprofloxacin, 124, 258, 556 pelvic plain films and, 70, 71 Circumferential resection margin intraabdominal abscess/wound synchronous, 389, 431 (CRM), 407 infection and, 151–152 uterine, 539 Citrucel. See Methylcellulose perineal wound infection and, Cancer and Leukemia Group B (CALGB), Citrus bioflavonoids, 160–161 152–153 470, 491 CLASICC trial, 693, 696, 703 prophylaxis colonoscopy and, 63 Cancer Genetics Studies Consortium, 358 Clavulanic acid, 124 Blood Cancer Prevention Study II, 340 Clindamycin, 124 supply, 15 Capsaicin (Dolorac; Zostrix), 241, 252 Clinical pathways, 137–138 transfusions, 326, 386 Carcinoembryonic antigen (CEA), Cloaca, 18, 718–719, 721–722 vessel invasion, 387 387–388, 446–447, 468 Clobetasol propionate (Temovate®), 252 Bone metastasis, 475 Carcinoid syndrome, 516–517 Clostridium botulinum, 185 Botulinum toxin (BT), 182, 185–187 Cascara, 681 Clostridium difficile, 124, 561, 617–618 Bowel. See also Mechanical bowel Case presentations, 780–781 CMS. See Centers for Medicare and preparation Catheters Medicaid Services activity/diet resumption, 694–695 balloon, 634 CMV. See Cytomegalovirus continence, 33
Load more

Recommended publications
  • Defecography: Technique, Interpretation, and Current Use Arden M
    9 Defecography: Technique, Interpretation, and Current Use Arden M. Morris and Susan C. Parker Defecography, or evacuation proctography, is the on technique, interpretation, and implications dynamic study of expulsion of radiopaque mate- for specific patient populations. rial from the rectum, in order to assess changing anatomic relationships of the pelvic floor and associated organs during evacuation. In 1952, Indications for Testing Wallden 1 first described enteroceles, sigmoido- celes, and rectoceles, using roentgenogram Constipation techniques developed to evaluate patients with symptoms of obstructed defecation. He postu- Defecography was initially developed to assess lated that such outlet obstruction was due to an patients with complaints of constipation and a abnormally deep rectogenital pouch and could sensation of rectal outlet obstruction. The diag- be corrected surgically. However, performing nostic armamentarium has expanded to include these static studies using rectal, vaginal, and anal manometry, electromyography, and colonic small bowel contrast was a cumbersome, expen- transit time studies, all of which are crucial for sive, and embarrassing process for the patient. distinguishing end-organ versus total organ Recognizing the limitations of these studies, etiologies. Therefore, although the major indi- subsequent authors streamlined the procedure cation for performing defecography continues to over the ensuing three decades. be constipation, other complaints may occasion- Broden and Snellman2 proposed the use of ally warrant defecographic evaluation. Table 9.1 cineradiographic methods and a physiologic demonstrates the primary indications and their position, which contributed enormously to the proportionate prevalence among our referred simultaneous study of function and anatomy. patients. There is considerable overlap in many Several centers built radiolucent commodes with of these symptoms and diagnoses.
    [Show full text]
  • An International Urogynecological
    AN INTERNATIONAL UROGYNECOLOGICAL ASSOCIATION (IUGA) / INTERNATIONAL CONTINENCE SOCIETY (ICS) JOINT REPORT ON THE TERMINOLOGY FOR FEMALE ANORECTAL DYSFUNCTION Abdul H Sultan^, Ash Monga # ^, Joseph Lee*^, Anton Emmanuel^, Christine Norton^, Giulio Santoro^, Tracy Hull^, Bary Berghmans #^, Stuart Brody^, Bernard T. Haylen *^, Standardization and Terminology Committees IUGA* & ICS#, Joint IUGA / ICS Working Group on Female Anorectal Terminology^ Abdul H Sultan, MB ChB, MD, FRCOG Urogynaecologist and Obstetrician Croydon University Hospital, Croydon. United Kingdom Ash Monga, MB ChB, FRCOG Urogynaecologist Princess Anne Hospital, Southampton. United Kingdom. Joseph Lee, MB ChB, FRANZCOG, CU Urogynaecologist Mercy Hospital for Women, Melbourne. Victoria. Australia. Anton Emmanuel, Gastroenterologist University College Hospital, London. United Kingdom Christine Norton, Professor of Clinical Nursing St Mary's Hospital, London. United Kingdom. Giulio Santoro, Colorectal surgeon Regional Hospital, Treviso. Italy. Tracy Hull, Professor of Surgery Cleveland Clinic Foundation, Cleveland. Ohio. U.S.A. Bary Berghmans, Clinical epidemiologist and physiotherapist Maastricht University Hospital, Maastricht. Netherlands. Stuart Brody, Professor of Psychology University of the West of Scotland, Paisley, United Kingdom Bernard T. Haylen, Professor University of New South Wales, Sydney. N.S.W. Australia. IUGA-ICS Terminology on Female Anorectal Dysfunction Sultan AH et al, Version 25 (16Mar14) Page 1 Correspondence to: Mr Abdul H Sultan, Urogynaecology and
    [Show full text]
  • Evidence Review H: Lifestyle and Conservative Management Options for Pelvic Organ Prolapse
    National Institute for Health and Care Excellence Final Urinary incontinence and pelvic organ prolapse in women: management [H] Evidence reviews for lifestyle and conservative management options for pelvic organ prolapse NICE guideline NG123 Evidence reviews April 2019 Final These evidence reviews were developed by the National Guideline Alliance hosted by the Royal College of Obstetricians and Gynaecologists FINAL Error! No text of specified style in document. Disclaimer The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or service users. The recommendations in this guideline are not mandatory and the guideline does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian. Local commissioners and/or providers have a responsibility to enable the guideline to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with compliance with those duties. NICE guidelines cover health and care in England. Decisions on how they apply in other UK countries are made by ministers in the Welsh Government, Scottish Government, and Northern Ireland Executive.
    [Show full text]
  • Pelvic Prolapse
    Pelvic Prolapse Symptoms and Treatment CYstOCELE RECTOCELE ENTEROCELE COMBINED To make an appointment or ask a question, call the Division of Colon and Rectal Surgery at 617-636-6190. 800 Washington Street For urgent problems, call the Tufts Medical Center Boston, MA 02111 operator at 617-636-5000 and ask for the 617-636-5000 on-call physician for Colon and Rectal Surgery. www.tuftsmedicalcenter.org 09-062 2011 Pelvic prolapse includes several condi- DIAGNOSES REPAIRS tions that occur when pelvic organs bulge Pelvic prolapse may include any of the following specific Surgery may include: down into or out of the vagina or rectum. conditions: ▶ Rectocele repair — rectal approach Most pelvic prolapse occurs in women. ▶ Rectocele: bulging of the rectum into the vagina ▶ Rectocele repair — vaginal approach ▶ Cystocele: bulging of the bladder into the vagina ▶ Rectocele repair — abdominal approach Factors that may increase the risk of pelvic prolapse ▶ Enterocele: bulging of loops of small intestine into ▶ Cystocele repair include: the vagina ▶ TVT — transvaginal tape repair ▶ advancing age ▶ Sigmoidocele: bulging of the sigmoid colon into ▶ Rectal prolapse repair — abdominal ▶ multiple or difficult deliveries the vagina ▶ Rectal prolapse repair — perineal ▶ injury to the pelvic organs or muscles ▶ Urinary incontinence: unable to control urine ▶ Perineoplasty ▶ smoking ▶ Fecal incontinence: unable to control stool or gas ▶ Other ▶ use of steroid medications ▶ Constipation ▶ chronic lung disease ▶ Uterine prolapse Although many women develop some degree of pelvic ▶ Rectal prolapse prolapse as they age, many do not need treatment. ▶ Vaginal prolapse Medical treatment may include pelvic floor exercises, vaginal creams (usually containing estrogen) or use of a pessary (vaginal support ring).
    [Show full text]
  • Prolapse Repair Using Non-Synthetic Material: What Is the Current Standard?
    Current Urology Reports (2019) 20:70 https://doi.org/10.1007/s11934-019-0939-8 LOWER URINARY TRACT SYMPTOMS & VOIDING DYSFUNCTION (J SANDHU, SECTION EDITOR) Prolapse Repair Using Non-synthetic Material: What is the Current Standard? Ricardo Palmerola1 & Nirit Rosenblum 1 # Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract Purpose of Review Due to recent concerns over the use of synthetic mesh in pelvic floor reconstructive surgery, there has been a renewed interest in the utilization of non-synthetic repairs for pelvic organ prolapse. The purpose of this review is to review the current literature regarding pelvic organ prolapse repairs performed without the utilization of synthetic mesh. Recent Findings Native tissue repairs provide a durable surgical option for pelvic organ prolapse. Based on recent findings of recently performed randomized clinical trials with long-term follow-up, transvaginal native tissue repair continues to play a role in the management of pelvic organ prolapse without the added risk associated with synthetic mesh. Summary In 2019, the FDA called for manufacturers of synthetic mesh for transvaginal mesh to stop selling and distributing their products in the USA. Native tissue and non-synthetic pelvic organ prolapse repairs provide an efficacious alternative without the added risk inherent to the utilization of transvaginal mesh. A recent, multicenter, randomized clinical trial demonstrated no clear advantage to the utilization of synthetic mesh. Furthermore, transvaginal native tissue repairs have demonstrated good long-term efficacy, particularly when anatomic success is not the sole metric used to define surgical success. Keywords Pelvicorganprolapse .Cystocele .Enterocele .Rectocele .Syntheticmesh .Transvaginal mesh .Uterosacralligament suspension .
    [Show full text]
  • Role of Conventional Radiology and Mri Defecography of Pelvic Floor
    Reginelli et al. BMC Surgery 2013, 13(Suppl 2):S53 http://www.biomedcentral.com/1471-2482/13/S2/S53 RESEARCHARTICLE Open Access Role of conventional radiology and MRi defecography of pelvic floor hernias Alfonso Reginelli1*, Graziella Di Grezia1, Gianluca Gatta1, Francesca Iacobellis1, Claudia Rossi1, Melchiore Giganti2, Francesco Coppolino3, Luca Brunese4 From 26th National Congress of the Italian Society of Geriatric Surgery Naples, Italy. 19-22 June 2013 Abstract Background: Purpose of the study is to define the role of conventional radiology and MRI in the evaluation of pelvic floor hernias in female pelvic floor disorders. Methods: A MEDLINE and PubMed search was performed for journals before March 2013 with MeSH major terms ‘MR Defecography’ and ‘pelvic floor hernias’. Results: The prevalence of pelvic floor hernias at conventional radiology was higher if compared with that at MRI. Concerning the hernia content, there were significantly more enteroceles and sigmoidoceles on conventional radiology than on MRI, whereas, in relation to the hernia development modalities, the prevalence of elytroceles, edroceles, and Douglas’ hernias at conventional radiology was significantly higher than that at MRI. Conclusions: MRI shows lower sensitivity than conventional radiology in the detection of pelvic floor hernias development. The less-invasive MRI may have a role in a better evaluation of the entire pelvic anatomy and pelvic organ interaction especially in patients with multicompartmental defects, planned for surgery. Introduction the pelvic examination alone has led to the need to use Pelvic floor disorders represent a significant cause of more direct and comprehensive diagnostic methods [3-6]. morbidity and reduction in quality of life that appear to Purposeofthestudyistodefinetheroleofconven- be increasing in frequency during the last few years [1].
    [Show full text]
  • Gastrointestinal Radiology
    2013 RSNA (Filtered Schedule) Sunday, December 01, 2013 10:45-12:15 PM • SSA06 • Room: E353A • Gastrointestinal (CT Dose Reduction I) 10:45-12:15 PM • SSA07 • Room: E450A • Gastrointestinal (Rectal Carcinoma Imaging) 10:45-12:15 PM • SSA08 • Room: E450B • Gastrointestinal (Hepatic Fibrosis Imaging) 10:45-12:15 PM • SSA23 • Room: E350 • Vascular/Interventional (Embolotherapy/Guidance Technology) 10:45-12:15 PM • SSA24 • Room: E352 • Vascular/Interventional (Portal Interventions/TIPS) 12:30-01:00 PM • LL-GIS-SUA • Room: Lakeside Learning Center • Gastrointestinal - Sunday Posters and Exhibits (12:30pm - 1:00pm) 01:00-01:30 PM • LL-GIS-SUB • Room: Lakeside Learning Center • Gastrointestinal - Sunday Posters and Exhibits (1:00pm - 1:30pm) 02:00-03:00 PM • MSRA13 • Room: S402AB • Abdominal Imaging Clinical Pathways (An Interactive Session) 02:00-03:30 PM • RC104 • Room: E353C • Sports Injuries in the Chest and Abdominal Wall: A Core Curriculum of the Body's Core 02:00-03:30 PM • RC109 • Room: E450A • Gastrointestinal: Liver (An Interactive Session) 03:15-04:15 PM • MSRA14 • Room: S402AB • Imaging the Bariatric Surgery Patient (An Interactive Session) Monday, December 02, 2013 08:30-12:00 PM • VSGI21 • Room: N227 • Gastrointestinal Series: Emerging Issues in Abdominal CT 10:30-12:00 PM • SSC05 • Room: E353A • Gastrointestinal (Hepatocellular Carcinoma Imaging) 10:30-12:00 PM • SSC06 • Room: E451A • Gastrointestinal (Oncology: Surveillance and Tumor Response) 10:30-12:00 PM • SSC16 • Room: E351 • Vascular/Interventional (Chemoembolization) 12:15-12:45
    [Show full text]
  • Diagnostic and Therapeutic Approach to Obstructed Defecation Syndrome W26, 30 August 2011 09:00 - 12:00
    Diagnostic and therapeutic approach to obstructed defecation syndrome W26, 30 August 2011 09:00 - 12:00 Start End Topic Speakers 09:00 09:05 Introduction Giulio Aniello Santoro 09:05 09:20 Anatomy of the pelvic floor and the posterior S. Abbas Shobeiri compartment 09:20 09:35 Pathophysiology of obstructed defecation syndrome Anders Mellgren 09:35 09:50 Ultrasonographic imaging in obstructed defecation Giulio Aniello Santoro syndrome 09:50 10:10 Defecography and dynamic MRI Andrzej Pawel Wieczorek 10:10 10:30 Discussion All 10:30 11:00 Break None 11:00 11:15 Anorectal manometry and neurophysiologic tests Giulio Aniello Santoro 11:15 11:30 Management of obstructed defecation syndrome Anders Mellgren 11:30 11:45 Pelvic Floor Rehabilitation and Biofeedback Julie Herbert 11:45 12:00 Questions All Aims of course/workshop Ostructed defecation syndrome (ODS)can be due to different reasons (rectocele, enterocele, rectal prolapse, intussusception, pelvic floor dyssynergy). Management of ODS depends on a comprehensive understanding of the anatomy and function of the anorectal region. Aims of this workshop are to provide participants the basic knowledge on: 1) the normal anatomy of the anorectum, 2) the diagnostic procedures including imaging techniques, manometric and neurophysiologic tests and 3) the main guidelines and indications for the treatment of ODS. Educational Objectives Highly regarded speakers of different specialties, including colorectal surgeons, radiologist and urogynecologist have been selected to provide their experiences on how to approach, from a practical point of view, patients with ostructed defecation syndrome Anatomy of the pelvic floor and the posterior compartment The pelvic organs rely on their connective tissue attachments to the pelvic walls and support from the levator ani muscles that are under neuronal control from the peripheral and central nervous systems.
    [Show full text]
  • Dynamic MRI of the Pelvic Floor
    Dynamic Magnetic Resonance Imaging of the Pelvic Floor Sindhura Alapati, MD,* and Kedar Jambhekar, MD Pelvic floor dysfunction is a widespread condition affecting up to 50% of elderly women. It markedly compromises the quality of life owing to various disabling symptoms such as pelvic pain, pelvic organ prolapse, and urinary and fecal incontinence. Although age and female sex are the main risk factors, others include multiparity, obesity, and connective tissue disorders. Pelvic floor dysfunction is frequently multicompartmental, and failure to diagnose it accurately often leads to treatment failure. Dynamic pelvic floor magnetic resonance imaging is a robust tool that enables simultaneous visualization of the 3 pelvic floor compartments and is indispensable for precise preoperative evaluation. Semin Ultrasound CT MRI 38:188-199 C 2017 Elsevier Inc. All rights reserved. Introduction of one or more pelvic organs through the hiatus secondary to ineffective support structures. This disorder can manifest as elvic floor dysfunction is an umbrella term for a spectrum prolapse of any of the following anatomical structures either in P of functional disorders affecting the 3 compartments of isolation or in combination with one another: urethra the pelvic floor, caused by impairment of the support (urethrocele), urinary bladder (cystocele) or both (cystoureth- ligaments, fasciae, and muscles. It is a prevalent disorder rocele), vaginal vault and cervix (vaginal prolapse), uterus 1 affecting up to 50% of women older than 50 years of age. It (uterine prolapse), rectum (anterior or posterior rectocele), affects 23.7% of women in the United States with a prevalence small bowel (enterocele), and peritoneum (peritoneocele). On 2,3 of 9.7%-49.7%, that increases with age.
    [Show full text]
  • Us 2018 / 0305689 A1
    US 20180305689A1 ( 19 ) United States (12 ) Patent Application Publication ( 10) Pub . No. : US 2018 /0305689 A1 Sætrom et al. ( 43 ) Pub . Date: Oct. 25 , 2018 ( 54 ) SARNA COMPOSITIONS AND METHODS OF plication No . 62 /150 , 895 , filed on Apr. 22 , 2015 , USE provisional application No . 62/ 150 ,904 , filed on Apr. 22 , 2015 , provisional application No. 62 / 150 , 908 , (71 ) Applicant: MINA THERAPEUTICS LIMITED , filed on Apr. 22 , 2015 , provisional application No. LONDON (GB ) 62 / 150 , 900 , filed on Apr. 22 , 2015 . (72 ) Inventors : Pål Sætrom , Trondheim (NO ) ; Endre Publication Classification Bakken Stovner , Trondheim (NO ) (51 ) Int . CI. C12N 15 / 113 (2006 .01 ) (21 ) Appl. No. : 15 /568 , 046 (52 ) U . S . CI. (22 ) PCT Filed : Apr. 21 , 2016 CPC .. .. .. C12N 15 / 113 ( 2013 .01 ) ; C12N 2310 / 34 ( 2013. 01 ) ; C12N 2310 /14 (2013 . 01 ) ; C12N ( 86 ) PCT No .: PCT/ GB2016 /051116 2310 / 11 (2013 .01 ) $ 371 ( c ) ( 1 ) , ( 2 ) Date : Oct . 20 , 2017 (57 ) ABSTRACT The invention relates to oligonucleotides , e . g . , saRNAS Related U . S . Application Data useful in upregulating the expression of a target gene and (60 ) Provisional application No . 62 / 150 ,892 , filed on Apr. therapeutic compositions comprising such oligonucleotides . 22 , 2015 , provisional application No . 62 / 150 ,893 , Methods of using the oligonucleotides and the therapeutic filed on Apr. 22 , 2015 , provisional application No . compositions are also provided . 62 / 150 ,897 , filed on Apr. 22 , 2015 , provisional ap Specification includes a Sequence Listing . SARNA sense strand (Fessenger 3 ' SARNA antisense strand (Guide ) Mathew, Si Target antisense RNA transcript, e . g . NAT Target Coding strand Gene Transcription start site ( T55 ) TY{ { ? ? Targeted Target transcript , e .
    [Show full text]
  • July/August, 2016 Volume 8 | Number 4 Ofpjournal.Com
    THE OFFICIAL PEER-REVIEWED PUBLICATION OF THE AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS July/August, 2016 Volume 8 | Number 4 ofpjournal.com EDITOR’S MESSAGE Summertime When Feet & Ankles are Bare REVIEW ARTICLES Common Orthopaedic Foot & Ankle Diagnoses Encountered in the Primary Care Setting Empathy and Its Role in Quality of Care Etiology, Evaluation and Osteopathic Management of Adult Constipation Dysuria CLINICAL IMAGES Uvulitis Inherited Patterned Lentiginosis: A Diagnosis of Exclusion PATIENT EDUCATION HANDOUT Plantar Fasciitis www.acofp.org 2016 CALL FOR PAPERS Osteopathic Family Physician is the ACOFP’s official peer-reviewed journal. The bi-monthly publication features original research, clinical images and articles Osteopathic Family Physician about preventive medicine, managed care, osteopathic principles and practices, pain management, public health, medical education and practice management. www.ofpjournal.com INSTRUCTIONS FOR AUTHORS Reserve a review article topic today by emailing ACOFP Managing Editor, Belinda Bombei at [email protected]. Please provide your name and the review title you would like to reserve. Once you reserve a review article topic, you will receive an email confirmation from ACOFP. This will initiate a three-month deadline for submission. If the paper is not received within three months, the system will release the review article topic for other authors to reserve. Articles submitted for publication must be original in nature and may not be published in any other periodical. Materials for publication should be of clinical or didactic interest to osteopathic family physicians. Any reference to statistics and/or studies must be footnoted. Material by another author must be in quotations and receive appropriate attribution.
    [Show full text]
  • Consensus Definitions and Interpretation Templates For
    AUGS JOINT PUBLICATION Consensus Definitions and Interpretation Templates for Fluoroscopic Imaging of Defecatory Pelvic Floor Disorders Proceedings of the Consensus Meeting of the Pelvic Floor Consortium of the American Society of Colon and Rectal Surgeons, the Society of Abdominal 12/28/2020 on BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdtwnfKZBYtws= by https://journals.lww.com/fpmrs from Downloaded Radiology, the International Continence Society, the American Urogynecologic Downloaded Society, the International Urogynecological Association, and the Society of from Gynecologic Surgeons https://journals.lww.com/fpmrs Ian Paquette, MD,* David Rosman, MD,† Rania El Sayed, MD,‡ Tracy Hull, MD,§ Ervin Kocjancic, MD,|| Lieschen Quiroz, MD,} Susan Palmer, MD,** Abbas Shobeiri, MD, MBA,†† Milena Weinstein, MD,‡‡ Gaurav Khatri, MD,§§ Liliana Bordeianou, MD, MPH,|||| and Members of the Expert Workgroup on Fluoroscopic Imaging of Pelvic Floor Disorders by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC1y0abggQZXdtwnfKZBYtws= all these specialists are dedicated to the care of patients with Key Words: defecography, dynamic defecogram, fluorodefecography, pelvic floor disorders, but sometimes approach evaluation pelvic floor proctogram and treatment of patients with pelvic floor complaints with (Female Pelvic Med Reconstr Surg 2021;27: e1–e12) differing perspectives, the PFDC was formed to arrange col- laboration between these specialties. The PFDC’s goal is
    [Show full text]